Fiona C. McKay

1.7k total citations
33 papers, 1.1k citations indexed

About

Fiona C. McKay is a scholar working on Immunology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Fiona C. McKay has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 8 papers in Pathology and Forensic Medicine and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Fiona C. McKay's work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers) and Streptococcal Infections and Treatments (7 papers). Fiona C. McKay is often cited by papers focused on Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers) and Streptococcal Infections and Treatments (7 papers). Fiona C. McKay collaborates with scholars based in Australia, United States and United Kingdom. Fiona C. McKay's co-authors include Graeme J. Stewart, David R. Booth, Stephen D. Schibeci, Mark J. Walker, Jason D. McArthur, Marie Ranson, Robert Heard, Martina Sanderson‐Smith, Grant P. Parnell and Steve Vucic and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The FASEB Journal.

In The Last Decade

Fiona C. McKay

32 papers receiving 1.0k citations

Peers

Countries citing papers authored by Fiona C. McKay

Since Specialization

Citations

This map shows the geographic impact of Fiona C. McKay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona C. McKay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona C. McKay more than expected).

Fields of papers citing papers by Fiona C. McKay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona C. McKay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona C. McKay. The network helps show where Fiona C. McKay may publish in the future.

Co-authorship network of co-authors of Fiona C. McKay

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona C. McKay. A scholar is included among the top collaborators of Fiona C. McKay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona C. McKay. Fiona C. McKay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expression of CYP24A1 and other multiple sclerosis risk genes in peripheral blood indicates response to vitamin D in homeostatic and inflammatory conditions 2021 ·Genes and Immunity ·(unknown), Prudence N. Gatt, Stephen D. Schibeci, Fiona C. McKay, Steve Vucic, Prue H. Hart, Scott N. Byrne, David A. Brown, Graeme J. Stewart, Christopher Liddle, Grant P. Parnell, David R. Booth	2
2	The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis 2017 ·Journal of Autoimmunity ·Nicole Fewings, Prudence N. Gatt, Fiona C. McKay, Grant P. Parnell, Stephen D. Schibeci, Jarem Edwards, (unknown), (unknown), Marzena J. Fabis‐Pedrini, Allan G. Kermode, (unknown), Jacob L. McCauley, Dorothee Nickles, Sergio E. Baranzini, Therese Burke, Steve Vucic, Graeme J. Stewart, David R. Booth	23
3	Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis 2017 ·Data in Brief ·Nicole Fewings, Prudence N. Gatt, Fiona C. McKay, Grant P. Parnell, Stephen D. Schibeci, Jarem Edwards, (unknown), (unknown), Marzena J. Fabis‐Pedrini, Allan G. Kermode, (unknown), Jacob L. McCauley, Dorothee Nickles, Sergio E. Baranzini, Therese Burke, Steve Vucic, Graeme J. Stewart, David R. Booth	5
4	The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies 2016 ·Clinical Immunology ·Fiona C. McKay, Prudence N. Gatt, Nicole Fewings, Grant P. Parnell, Stephen D. Schibeci, (unknown), Joseph E. Powell, (unknown), Marzena J. Fabis‐Pedrini, Allan G. Kermode, Therese Burke, Steve Vucic, Graeme J. Stewart, David R. Booth	17
5	The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function 2015 ·PLoS ONE ·Judith Field, (unknown), Stephen D. Schibeci, Laura Johnson, Melissa Gresle, Louise Laverick, Grant P. Parnell, Graeme J. Stewart, Fiona C. McKay, Trevor J. Kilpatrick, Helmut Butzkueven, David R. Booth	39
6	The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease 2014 ·Clinical Immunology ·Grant P. Parnell, Prudence N. Gatt, Małgorzata Krupa, Dorothee Nickles, Fiona C. McKay, Stephen D. Schibeci, Marcel Batten, Sergio E. Baranzini, Andrew Henderson, Michael Barnett, Mark Slee, Steve Vucic, Graeme J. Stewart, David R. Booth	44
7	IL7Rα Expression and Upregulation by IFNβ in Dendritic Cell Subsets Is Haplotype-Dependent 2013 ·PLoS ONE ·Fiona C. McKay, (unknown), Grant P. Parnell, Prudence N. Gatt, Stephen D. Schibeci, Graeme J. Stewart, David R. Booth	9
8	A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis 2010 ·PLoS ONE ·Carlos Riveros, (unknown), Kaushal Gandhi, Fiona C. McKay, Mathew Cox, Regina Berretta, (unknown), Mario Inostroza-Ponta, Simon Broadley, Robert Heard, Steve Vucic, Graeme J. Stewart, David W. Williams, Rodney J. Scott, Jeannette Lechner‐Scott, David R. Booth, Pablo Moscato	46
9	Interleukin 7 Receptor Alpha Chain Haplotypes Vary in Their Influence on Multiple Sclerosis Susceptibility and Response to Interferon Beta 2010 ·Journal of Interferon & Cytokine Research ·(unknown), Fiona C. McKay, (unknown), (unknown), Graeme J. Stewart, David R. Booth	20
10	Parameters Governing Invasive Disease Propensity of Non-M1 Serotype Group A Streptococci 2010 ·Journal of Innate Immunity ·Peter G. Maamary, Martina Sanderson‐Smith, Ramy K. Aziz, Andrew Hollands, Jason N. Cole, Fiona C. McKay, Jason D. McArthur, (unknown), Amanda J. Cork, Rachael J. Keefe, Rita G. Kansal, Hongmin Sun, William L. Taylor, Gursharan S. Chhatwal, David Ginsburg, Victor Nizet, Malak Kotb, Mark J. Walker	31
11	Novel Approaches to Detect Serum Biomarkers for Clinical Response to Interferon-β Treatment in Multiple Sclerosis 2010 ·PLoS ONE ·Kaushal Gandhi, Fiona C. McKay, Eve Diefenbach, Ben Crossett, Stephen D. Schibeci, Robert Heard, Graeme J. Stewart, David R. Booth, Jonathan W. Arthur	15
12	BAFF is a Biological Response Marker to IFN-β Treatment in Multiple Sclerosis 2008 ·Journal of Interferon & Cytokine Research ·Kaushal Gandhi, Fiona C. McKay, Stephen D. Schibeci, Jonathan W. Arthur, (unknown), Graeme J. Stewart, David R. Booth	26
13	Use of Cryopreserved Cells for Enabling Greater Flexibility in Compound Profiling 2008 ·SLAS DISCOVERY ·Mark Wigglesworth, (unknown), (unknown), (unknown), (unknown), Fiona C. McKay, E. Sally Ward, Stephen Brough, Marinos Stylianou, Frances Jewitt, (unknown), (unknown), (unknown), (unknown), Jing Ding, Alan Wise	15
14	Identification of small molecule agonists of the motilin receptor 2008 ·Bioorganic & Medicinal Chemistry Letters ·Tom D. Heightman, (unknown), David F. Corbett, Gregor J. Macdonald, Geoffrey Stemp, Susan M. Westaway, (unknown), Stefania Gagliardi, (unknown), Silvano Ronzoni, Kalindi Vaidya, (unknown), Fiona C. McKay, Alison I. Muir, (unknown), Kim Winborn, Alan Wise, Emma M. Jarvie, Gareth J. Sanger	11
15	CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis 2008 ·Journal of Autoimmunity ·Fiona C. McKay, (unknown), Stephen D. Schibeci, Justin P. Rubio, Trevor J. Kilpatrick, Robert Heard, Graeme J. Stewart, David R. Booth	24
16	Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jason Witherington, (unknown), Benjamin R. Bellenie, (unknown), (unknown), David K. Dean, Alessandra Gaiba, N. Paul King, (unknown), Jon G.A. Steadman, Andrew K. Takle, Gareth J. Sanger, (unknown), Fiona C. McKay, Alison I. Muir, Kim Winborn, Robert W. Ward, Tom D. Heightman	2
17	Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis 2007 ·Genes and Immunity ·Fiona C. McKay, (unknown), Stephen D. Schibeci, Justin P. Rubio, Trevor J. Kilpatrick, Robert Heard, Graeme J. Stewart, David R. Booth	54
18	Trigger for group A streptococcal M1T1 invasive disease 2006 ·The FASEB Journal ·Jason N. Cole, Jason D. McArthur, Fiona C. McKay, Martina Sanderson‐Smith, Amanda J. Cork, Marie Ranson, Manfred Rohde, Andreas Itzek, Hongmin Sun, David Ginsburg, Malak Kotb, Victor Nizet, G. S. Chhatwal, Mark J. Walker	128
19	Is plasminogen deployed as a Streptococcus pyogenes virulence factor? 2005 ·Trends in Microbiology ·Mark J. Walker, Jason D. McArthur, Fiona C. McKay, Marie Ranson	96
20	Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: A comparison of three methods in a large Australasian cohort 2005 ·Journal of Immunological Methods ·Fiona C. McKay, Stephen D. Schibeci, Robert Heard, Graeme J. Stewart, David R. Booth	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact